Skip to content
PharmaManufacturingIQ

Keeping up with biologics: The challenges for primary packaging and delivery systems

Here, Rich Quelch, global head of marketing, Origin, looks at the challenges involved in primary packaging and delivery systems for biologics.

By Richard Quelch
Keeping up with biologics: The challenges for primary packaging and delivery systems
Published: | 4 min read
Share to X Share to Bluesky Share to Facebook Share to LinkedIn Share by email

Here, Rich Quelch, global head of marketing, Origin, looks at the challenges involved in primary packaging and delivery systems for biologics.

GSK, Bristol-Myers Squibb, Novartis and AstraZeneca to name but a few are investing billions of dollars in biologics to have prime mover advantage in a market forecast to be worth nearly $480 billion by 2024.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information